NEWS
Dr. David T. Rubin Discusses the Efficacy and Safety of JAK Inhibitors
Click here to read Conference Coverage on Dr. Rubin’s talk at AIBD Virtual Regionals 2023, “JAK Inhibitors: Efficacy and Safety.” He details the pivotal clinical trials that help us understand JAK-inhibitors, as well as real-world evidence of their success in patients.
Dr. David T. Rubin Presents a Talk on Exit Strategy from Maintenance Therapy in IBD for the Asian Institute of Gastroenterology 2023 Summit
Click here to watch the full video of Dr. Rubin’s presentation on exit strategies from maintenance therapy, including discussion of the reasons for why, when, how, and if you should stop IBD therapy with specific focus on biologics, 5-ASA, and azathioprine.
Dr. David T. Rubin Hosts Pearls from the Pros on IBD Management
Dr. Rubin hosted four episodes of MedEd Talks Gastroenterology’s Pearls from the Pros on IBD Management, featuring several colleagues to discuss best practices in using different classes of IBD therapies. Dr. Rubin spoke with Dr. Bruce Sands, Gastroenterologist and Professor of Medicine at Mount Sinai, about best practices in anti-IL-12/23 therapies. With Dr. Millie Long, Associate Professor in the Department of Medicine, Division of Gastroenterology and Hepatology at University of North Carolina at Chapel Hill, Dr. Rubin discussed JAK inhibitors and their role in clinical practice. Dr. Stephen Hanauer, Professor of Medicine in Gastroenterology and Hepatology at Northwestern University, shared his expertise on Anti-TNF therapy. Finally, Dr. Rubin talked about small-molecule therapies, including S1P receptor modulation and anti-integrin therapies, with Dr. Maria T. Abreu, Professor of Medicine and Director of the Crohn’s and Colitis Center at the University of Miami.
David T. Rubin Accepts the 2020 Sherman Prize
Watch David T. Rubin accept the 2020 Sherman Prize, which is awarded to IBD clinicians, surgeons, researchers and/or academics with extraordinary track records of achievement, making exceptional and pioneering contributions that transform IBD care.
Dr. David T. Rubin Shares Expert Advice on How to Get Your Work Published
Originally presented at the Crohn’s and Colitis Congress with colleagues Fabio Cominelli, MD, PhD, of Case Western Reserve University, and Siddharth Singh, MD, of the University of California San Diego, Rubin highlighted the importance of choosing the most appropriate journal, sending pre-submission inquiries, creating a compelling cover letter and more.
To watch the complete video, click here
Dr. David T. Rubin Reflects on How to Avoid the Next Pandemic with WGN’s Steve Dale
Click here to listen to the full interview.
Dr. David T. Rubin Summarizes His Presentation from the Advances in Inflammatory Bowel Diseases Conference on Preparing for IBD Care in the Next Pandemic
Click here for the full video of Dr. Rubin detailing his 8-point strategy for steps the gastroenterology community should take to prepare for another pandemic in the future to ensure the best outcomes for patients and conditions for professionals.
Newly Discovered Vascular Barrier in the Brain May Explain IBD-Related Anxiety, Depression
A newly discovered vascular brain barrier that blocks the passage of inflammatory molecules triggered by gut bacteria may be why patients with inflammatory bowel disease (IBD) are at increased risk for certain mental health disorders, including anxiety and depression, early research suggests.
Click here to read the full article, and here to read the publication “Identification of a choroid plexus vascular barrier closing during intestinal inflammation” in Science.
Dr. David T. Rubin Reviews His Presentation from the American College of Gastroenterology Scientific Meeting on Therapeutic Drug Monitoring in IBD
Click here for the full video of Dr. Rubin reviewing his presentation from the American College of Gastroenterology Scientific Meeting on therapeutic drug monitoring (TDM), including the appropriate application of proactive TDM in the treatment of inflammatory bowel disease.